- Home
- APLT vs AMAL Comparison
APLT vs AMAL Comparison
Compare APLT & AMAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- AMAL
- Stock Information
- Founded
- APLT 2016
- AMAL 1923
- Country
- APLT United States
- AMAL United States
- Employees
- APLT N/A
- AMAL N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- AMAL Commercial Banks
- Sector
- APLT Health Care
- AMAL Finance
- Exchange
- APLT Nasdaq
- AMAL Nasdaq
- Market Cap
- APLT 63.6M
- AMAL 858.7M
- IPO Year
- APLT 2019
- AMAL 2018
- Fundamental
- Price
- APLT $0.45
- AMAL $28.46
- Analyst Decision
- APLT Buy
- AMAL Hold
- Analyst Count
- APLT 6
- AMAL 2
- Target Price
- APLT $6.10
- AMAL $33.00
- AVG Volume (30 Days)
- APLT 771.9K
- AMAL 157.7K
- Earning Date
- APLT 11-06-2025
- AMAL 10-23-2025
- Dividend Yield
- APLT N/A
- AMAL 2.03%
- EPS Growth
- APLT N/A
- AMAL 3.73
- EPS
- APLT N/A
- AMAL 3.34
- Revenue
- APLT $121,000.00
- AMAL $304,724,000.00
- Revenue This Year
- APLT N/A
- AMAL $9.82
- Revenue Next Year
- APLT $5,931.24
- AMAL $11.11
- P/E Ratio
- APLT N/A
- AMAL $8.26
- Revenue Growth
- APLT N/A
- AMAL 4.35
- 52 Week Low
- APLT $0.30
- AMAL $25.03
- 52 Week High
- APLT $10.62
- AMAL $38.19
- Technical
- Relative Strength Index (RSI)
- APLT 48.46
- AMAL 45.99
- Support Level
- APLT $0.40
- AMAL $27.41
- Resistance Level
- APLT $0.46
- AMAL $29.19
- Average True Range (ATR)
- APLT 0.03
- AMAL 0.65
- MACD
- APLT -0.01
- AMAL -0.04
- Stochastic Oscillator
- APLT 36.84
- AMAL 46.08
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About AMAL Amalgamated Financial Corp. (DE)
Amalgamated Financial Corp is a bank holding company. It is a full-service commercial bank and a chartered trust company. It provides commercial banking and trust services nationally and offers various products and services to commercial and retail customers. It offers a complete suite of commercial and retail banking, investment management and trust and custody services.